Literature DB >> 6500375

Synchronous carcinomas of the uterine corpus and ovary.

R J Zaino, E R Unger, C Whitney.   

Abstract

The coexistence of carcinoma in the endometrium and ovary is a relatively uncommon but not rare occurrence. In general it has not been possible to determine which, if any, of these tumors represent metastases from endometrium or ovary or separate primary neoplasms, and gynecologists are unable to agree upon appropriate therapy. Twenty-four women with synchronous carcinomas of the ovary and endometrium in whom disease was confined to the pelvis, diagnosed at the Milton S. Hershey Medical Center between 1970 and 1982, were identified. Thirteen women had typical endometrial adenocarcinoma and endometrioid carcinoma of the ovary (Group A), two had unusual variants of endometrial carcinoma and a similar appearing tumor in the ovary (Group B), and nine had typical endometrial adenocarcinoma with carcinomas in the ovary of differing histologic appearance (Group C). There was no significant difference in survival between women in Groups A and C (77 and 56%, respectively, mean follow-up approximately 40 months). However, deep myometrial invasion (outer third) provided a statistically significant indicator of poor prognosis (77% with deep invasion vs 17% with superficial invasion recurred or died of disease P less than 0.05, chi 2 test).

Entities:  

Mesh:

Year:  1984        PMID: 6500375     DOI: 10.1016/0090-8258(84)90200-2

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Risk-based stratification of carcinomas concurrently involving the endometrium and ovary.

Authors:  Gulisa Turashvili; Natalia R Gómez-Hidalgo; Jessica Flynn; Mithat Gonen; Mario M Leitao; Robert A Soslow; Rajmohan Murali
Journal:  Gynecol Oncol       Date:  2018-11-06       Impact factor: 5.482

2.  Endometrial Cancer: Comparison of Patients with Synchronous Primary Carcinoma of the Endometrium and Ovary vs. Endometrial Carcinoma with Ovarian Metastases.

Authors:  I Juhasz-Böss; T Fehm; S Becker; R Rothmund; B Krämer; A Staebler; D Wallwiener; E F Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-08-16       Impact factor: 2.915

3.  Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.

Authors:  M M AlHilli; S C Dowdy; A L Weaver; J L St Sauver; G L Keeney; A Mariani; K C Podratz; J N Bakkum-Gamez
Journal:  Gynecol Oncol       Date:  2011-12-28       Impact factor: 5.482

Review 4.  Practical issues related to uterine pathology: staging, frozen section, artifacts, and Lynch syndrome.

Authors:  Robert A Soslow
Journal:  Mod Pathol       Date:  2016-01       Impact factor: 7.842

5.  Synchronous bilateral endometrioid ovarian cancer and uterine adenocarcinoma in a young woman.

Authors:  Mansour Al-Moundhri; Mariam Mathew; Andrzej Krolikowski
Journal:  J Sci Res Med Sci       Date:  2001-04

Review 6.  Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms.

Authors:  Daichi Maeda; Ie-Ming Shih
Journal:  Adv Anat Pathol       Date:  2013-01       Impact factor: 3.875

7.  Complete Response to Immunotherapy Combined With Chemotherapy in a Patient With Gynecological Mixed Cancer Mainly Composed of Small Cell Neuroendocrine Carcinoma With High Tumor Mutational Burden: A Case Report.

Authors:  Xingyun Su; Xinhui Zhou; Cheng Xiao; Wei Peng; Qiangfeng Wang; Yulong Zheng
Journal:  Front Oncol       Date:  2022-06-20       Impact factor: 5.738

8.  Endometrium and ovarian cancer synchronous to endometriosis--a retrospective study of our experience of 7 years.

Authors:  Ioannis Grammatikakis; Stefanos Zervoudis; Nikolaos Evangelinakis; Vasiliki Tziortzioti
Journal:  J Med Life       Date:  2010 Jan-Mar

Review 9.  Intraoperative consultation for ovarian tumors.

Authors:  Insun Kim
Journal:  Yeungnam Univ J Med       Date:  2019-06-11

Review 10.  ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.

Authors:  Eleftherios P Samartzis; Aurelia Noske; Konstantin J Dedes; Daniel Fink; Patrick Imesch
Journal:  Int J Mol Sci       Date:  2013-09-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.